Controlling the industrial crystallisation process poses a significant obstacle in the production of drugs and numerous other products. Digitisation of the crystallisation process now allows for radical change by increasing process automation to control overall crystallisation. The main pillars of Pharma 4.0 are process automation, improved control strategies, data visualisation, cloud edge storage, chemometrics, and mathematical modelling technologies. SmartCrys is a revolutionary integrated process control system that harnesses the mainstays of Pharma 4.0 with the combination of PAT tools in order to digitise the crystallisation process and achieve total process control.
Innopharma Technology will be attending and presenting at the IFPAC annual conference once again in February this year. IFPAC brings together experienced pharmaceutical professionals and the next generation of leaders to share in discussions, give input, and get ideas for the future well-being of the industry. The conference continues to set precedence as a forum for insightful discussions around the latest trends and real-life applications in the fields of Process Control, Quality by Design, Process Analytical Technology, Emerging Technologies, Quality Metrics, and Continuous Manufacturing applications for the pharmaceutical, biotechnology, generic, chemical, petrochemical, food, and related industries.
Our team of Pharma 4.0 experts looks forward to delivering not 1 but 2 presentations on Innopharma Technology’s Advanced Manufacturing platform, SmartX, while also engaging in plenty of application conversations at our booth, No. 417.
Make sure you attend the presentations, where:
Chris O’Callaghan, Head of Engineering, will be presenting on “Pharma 4.0 Self-Guided Control of a Fluid Bed Granulation Process.”
Claude Lacey, Principal Software Architect, will be presenting on “Advanced Manufacturing – Technology Enablers: An insight into building a Smart Platform”.
The ISPE Europe Pharma 4.0™ Conference is an interactive forum where top business leaders and CEOs of the industry discuss their strategic plans for the future of pharmaceutical engineering with the implementation of digitalisation.
The two-day event answered questions like:
How digitalisation will help us achieve new levels of connection, transparency, agility and productivity?
Why “functional silos” will be eliminated after digitalisation is successfully implemented?
How the pharma industry is driven by current practise with globally connected systems?
How, in a Pharma 4.0™ world, it will be feasible to be connected, while respecting and applying different cultures and management styles?
Unlike other huge events, attendees had the opportunity to connect directly with knowledgeable presenters representing leading organisations, including FDA, GSK, LifeBee, MHRA, Merck, Siemens UK, Werum IT Solutions, and more.
The workshop combines theoretical and regulatory background with practical experiences in the technical and in the GMP lab. It introduces to the principles of Quality by Design (QbD), late stage Process Analytical Technologies (PAT) and includes case studies from real industry life.
China Pharmaceutical Machinery Exposition, organized by China Association for Pharmaceutical Equipment and co-organized by the municipal government of the city where the exhibition is held, holds twice a year. It has been successfully held for over 57 times. With 29 years of contributing to the China pharmaceutical industry, CIPM has firmly established itself as the largest show for pharmaceutical manufacturing in China. CIPM is the World’s largest exhibition specialized in pharmaceutical manufacturing with 1,200 exhibitors including 400 international companies. It’s attendance figures boast 80,000 professional visitors and the conference hosts 60 forums & seminars.